Published in Clin Exp Immunol on May 01, 1995
Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure? Immunology (2004) 1.03
Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide. Clin Exp Immunol (2003) 0.94
Induction of murine thyroiditis by a non dominant E(k)-restricted peptide of human thyroglobulin. Immunology (2003) 0.88
Antibodies cross-reacting with thyroglobulin and thyroid peroxidase are induced by immunization of rabbits with an immunogenic thyroglobulin 20mer peptide. Clin Exp Immunol (2004) 0.77
Hypothyroidism, the main thyroid dysfunction in Iranian patients with myasthenia gravis: A case serie. Iran J Neurol (2011) 0.75
Thymectomy Cures Diabetes Mellitus and Ameliorates Myasthenia Gravis in a Patient with Thymus Hyperplasia and Hyperthyroidism: Report of a Case. Indian J Surg (2015) 0.75
Effect of Advanced Glycation End Products on Human Thyroglobulin's Antigenicity as Identified by the Use of Sera from Patients with Hashimoto's Thyroiditis and Gestational Diabetes Mellitus. Int J Endocrinol (2015) 0.75
Evolution, immunity and the emergence of brain superautoantigens. F1000Res (2017) 0.75
Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease. Front Immunol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology (1976) 4.93
Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol (1982) 4.21
Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today (1991) 3.35
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science (1974) 2.69
Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol (1983) 2.53
Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature (1986) 2.32
High frequency of natural autoantibodies in normal newborn mice. J Immunol (1985) 2.17
An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol (1977) 2.10
Autoimmune thyroid disease: developments in our understanding. Endocr Rev (1984) 1.98
MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS. Lancet (1963) 1.95
Myasthenia gravis. Adv Immunol (1988) 1.86
Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet (1975) 1.84
An enzyme-linked immunoassay for thyroid microsomal antibodies. J Immunol Methods (1982) 1.79
Production and assay of antibodies to acetylcholine receptors. Methods Enzymol (1981) 1.73
Physicochemical behaviour and structural characteristics of membrane-bound acetylcholinesterase from Torpedo electric organ. Effect of phosphatidylinositol-specific phospholipase C. Biochem J (1985) 1.42
Profile of the disulfide bonds in acetylcholinesterase. J Biol Chem (1986) 1.42
AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS. N Engl J Med (1964) 1.29
Formation of thyroid hormones. Vitam Horm (1982) 1.26
Control of thyroglobulin synthesis and secretion. (First of two parts). N Engl J Med (1979) 1.18
THE STRUCTURE OF THYROGLOBULIN AND ITS ROLE IN IODINATION. Recent Prog Horm Res (1965) 1.18
Graves' disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc (1970) 1.17
Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: possible functional and clinical significance. Biochem Biophys Res Commun (1986) 1.16
The dependence of acetylcholinesterase aggregation at low ionic strength upon a polyanionic component. Eur J Biochem (1978) 1.14
Immune complex deposits in Graves' disease and Hashimoto's thyroiditis. Am J Med (1977) 1.08
Autoantigenic determinants on human thyroglobulin. II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects. Clin Immunol Immunopathol (1990) 1.05
HLA antigens in Graves' disease. Acta Endocrinol (Copenh) (1977) 1.04
Towards an antigenic map of human thyroglobulin: identification of ten epitope-bearing sequences within the primary structure of thyroglobulin. J Endocrinol (1989) 0.96
Neurologic complications of thyroid dysfunction. Adv Neurol (1978) 0.91
Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91
The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies. Mol Neurobiol (1991) 0.90
Myasthenia gravis associated with Graves' disease in Japan. Jpn J Med (1987) 0.90
Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects. J Immunol (1989) 0.88
Natural autoantibodies in nude and normal outbred (Swiss) and inbred (BALB/c) mice. J Autoimmun (1989) 0.85
Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc Natl Acad Sci U S A (1990) 0.83
Genetic factors in Graves' ophthalmopathy. Clin Endocrinol (Oxf) (1986) 0.83
When and how to follow patients after treatment for hyper- and hypothyroidism? J Endocrinol Invest (1986) 0.80
Acetylcholinesterase antibodies and thyroid autoimmunity. Clin Exp Immunol (1988) 0.79
The molecular genetics of three thyroid autoantigens: thyroglobulin, thyroid peroxidase and the thyrotropin receptor. Autoimmunity (1990) 0.78
IgA class and subclass thyroid auto-antibodies in Graves' disease and Hashimoto's thyroiditis. Int Arch Allergy Appl Immunol (1987) 0.77
Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies. J Biol Chem (1981) 2.62
Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol (1983) 2.53
Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci U S A (1980) 2.42
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol (1997) 2.35
Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 2.22
High frequency of natural autoantibodies in normal newborn mice. J Immunol (1985) 2.17
Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care (1998) 1.94
Mapping the main immunogenic region and toxin-binding site of the nicotinic acetylcholine receptor. Science (1987) 1.57
Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm (1997) 1.30
Studies on natural antibodies and autoantibodies. Ann Immunol (Paris) (1983) 1.27
Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera. J Immunol (1985) 1.19
Alpha subunit composition of nicotinic acetylcholine receptors in the rat autonomic ganglia neurons as determined with subunit-specific anti-alpha(181-192) peptide antibodies. Neuroscience (1999) 1.19
Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab (1983) 1.15
Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol (1999) 1.13
A high incidence of cross-reactive idiotypes among murine natural autoantibodies. Eur J Immunol (1985) 1.07
Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit. Proc Natl Acad Sci U S A (1987) 1.04
Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry (2001) 1.04
Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann N Y Acad Sci (1986) 1.03
Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Eur J Immunol (1992) 1.03
The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol (Oxf) (2003) 1.02
Antigenic sites of the nicotinic acetylcholine receptor cannot be predicted from the hydrophilicity profile. FEBS Lett (1984) 0.99
Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit. J Biol Chem (1988) 0.99
Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin. J Immunol (1999) 0.98
The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania mimics the Arg-Gly-Asp-Ser cell attachment region of fibronectin. J Biol Chem (1992) 0.96
Anterior, posterior, or laparoscopic approach for the management of adrenal diseases? Am J Surg (1997) 0.95
Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. J Leukoc Biol (1996) 0.95
Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice. Arthritis Rheum (2001) 0.95
Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent. J Endocrinol Invest (2003) 0.94
Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide. Clin Exp Immunol (2003) 0.94
Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care (1995) 0.93
Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera. J Autoimmun (1989) 0.92
Perception of family support is correlated with glycemic control in Greeks with diabetes mellitus. Psychol Rep (2001) 0.91
Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis. J Immunol (1993) 0.91
Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism? J Endocrinol Invest (1991) 0.90
B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor. Eur J Immunol (1988) 0.90
Conformation of cytoplasmic segments of acetylcholine receptor alpha- and beta-subunits probed by monoclonal antibodies: sensitivity of the antibody competition approach. EMBO J (1987) 0.89
Lipid-dependent recovery of alpha-bungarotoxin and monoclonal antibody binding to the purified alpha-subunit from Torpedo marmorata acetylcholine receptor. Enhancement by noncompetitive channel blockers. J Biol Chem (1984) 0.88
Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor. Eur J Immunol (1998) 0.87
Severe congenital myasthenic syndrome due to homozygosity of the 1293insG epsilon-acetylcholine receptor subunit mutation. Ann Neurol (2000) 0.86
The relation of serum T4 and TSH with the urinary iodine excretion. J Endocrinol Invest (1988) 0.86
Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis. Clin Exp Immunol (1984) 0.86
Decreased stature in gestational diabetes mellitus. Diabetologia (1998) 0.85
Prevention of passively transferred experimental autoimmune myasthenia gravis by Fab fragments of monoclonal antibodies directed against the main immunogenic region of the acetylcholine receptor. J Neuroimmunol (2000) 0.85
High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor. J Neuroimmunol (1999) 0.85
Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA. J Clin Lab Anal (2002) 0.85
Sustained remission of metastatic adrenal carcinoma during long-term administration of low-dose mitotane. J Endocrinol Invest (2001) 0.85
B-cell autoepitopes on the acetylcholinesterase-homologous region of human thyroglobulin: association with Graves' disease and thyroid eye disease. Eur J Endocrinol (2001) 0.84
Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate. J Immunol (1986) 0.84
Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to alpha, beta and gamma subunits. FEBS Lett (1986) 0.84
Localisation of the main immunogenic region of the nicotinic acetylcholine receptor. FEBS Lett (1986) 0.83
Bacterial expression of a single-chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies. Eur J Immunol (1993) 0.82
Nicotinic acetylcholine receptor: structure, function and main immunogenic region. Adv Neuroimmunol (1994) 0.82
Does coffee consumption protect against thyroid disease? Acta Chir Scand (1989) 0.82
Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor. Biochem J (1990) 0.82
The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor. Eur J Biochem (2000) 0.82
Monoclonal antibodies against the main immunogenic region of the acetylcholine receptor. Mapping on the intact molecule. J Neuroimmunol (1989) 0.82
Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece. Eur J Neurol (2009) 0.82
The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol (Oxf) (1992) 0.81
Antigenic sites of the nicotinic acetylcholine receptor. Biochem J (1985) 0.81
High-resolution epitope mapping and fine antigenic characterization of the main immunogenic region of the acetylcholine receptor. Improving the binding activity of synthetic analogues of the region. Eur J Biochem (1993) 0.81
Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins. Clin Exp Immunol (1990) 0.81
Equal male and female incidence of myasthenia gravis. Neurology (2000) 0.81
Cellular ageing related proteins secreted by human fibroblasts. Mutat Res (1992) 0.81
Autoimmunity induced by HgCl2 in Brown-Norway rats. II. Monoclonal antibodies sharing specificities and idiotypes with mouse natural monoclonal antibodies. J Immunol (1986) 0.80
Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term. Eur J Endocrinol (2000) 0.80
Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor. Clin Exp Immunol (2004) 0.80
The gender gap in autoimmune disease. Lancet (2001) 0.80
Free-thyroxine index in schizophrenic patients before and after neuroleptic treatment. Neuropsychobiology (1980) 0.80
Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with or without insulin-dependent diabetes mellitus. Autoimmunity (1995) 0.80
Obtaining resources for evidence-based public health initiatives at the local level: insights from the Central Sydney Tobacco Control Plan. Aust N Z J Public Health (1999) 0.80
Study of the Trp64Arg polymorphism of the beta3-adrenergic receptor in Greek women with gestational diabetes. Diabetes Care (2000) 0.80
Two-dimensional 1H-NMR study of antigen-antibody interactions: binding of synthetic decapeptides to an anti-acetylcholine receptor monoclonal antibody. Biopolymers (1991) 0.80
Treatment of passively transferred experimental autoimmune myasthenia gravis using papain. Clin Exp Immunol (2000) 0.79
A shared epitope in the acetylcholine receptor-alpha subunit and fast troponin I of skeletal muscle. Is it important for myasthenia gravis? Am J Pathol (1992) 0.79
Secretor status and infection in patients with Graves' disease. Autoimmunity (1990) 0.79
Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria. Cardiovasc Res (1997) 0.79
Amylin/islet amyloid polypeptide expression in medullary carcinoma of the thyroid: correlation with the expression of the related calcitonin/CGRP genes. Clin Endocrinol (Oxf) (1994) 0.78
Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies. Eur J Biochem (2001) 0.78
HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease. J Endocrinol Invest (2001) 0.78
Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor. J Neuroimmunol (1999) 0.78
Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease. J Autoimmun (2003) 0.78
Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients. Neuropsychobiology (1986) 0.78
Increased natural antibody activity in sera of patients with malignant non-Hodgkin's lymphomas containing paraproteins. Am J Hematol (1994) 0.77
High plasma amylin/islet amyloid polypeptide levels in patients with residual medullary thyroid carcinoma after total thyroidectomy. Eur J Endocrinol (2001) 0.77
Hormonal parameters in gestational diabetes mellitus during the third trimester: high glucagon levels. Gynecol Obstet Invest (2000) 0.77
2D-NMR and molecular dynamics analysis of the Torpedo californica acetylcholine receptor alpha 67-76 fragment and of its [Ala76]-analogue. Pept Res (1992) 0.77
A group of three fibroblast secreted polypeptides suppressed by cellular ageing and interferon-gamma. Biochim Biophys Acta (1993) 0.77
Antibodies cross-reacting with thyroglobulin and thyroid peroxidase are induced by immunization of rabbits with an immunogenic thyroglobulin 20mer peptide. Clin Exp Immunol (2004) 0.77
The plasma inorganic iodine and the pituitary-thyroid axis in pregnancy. J Endocrinol Invest (1978) 0.77
Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera. Eur J Immunol (1992) 0.77